Raymond H J Staals

Scopus Author ID Digital author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

Nucleic acids research

Science (New York, N.Y.)

The CRISPR journal

Nature communications

Wageningen University and Research Centre

Radboud Universiteit Nijmegen Nijmegen Centre for Molecular Life Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wageningen University and Research Centre Jan 01 2017

Netherlands

Assistant Professor :: Microbiology

University of Otago - Dec 31 2016

New Zealand

Research Fellow :: Department of Microbiology and Immunology

Wageningen Universiteit en Researchcentrum

Netherlands

Research Fellow :: Laboratory of Microbiology

Blariacumcollege

Netherlands

High School Biology Teacher

Education History

Radboud Universiteit Nijmegen Nijmegen Centre for Molecular Life Sciences

Netherlands

PHD :: Biomolecular Chemistry

Utrecht University

Netherlands

MSC

Publications

Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals, Johannes Hohlbein
Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Nucleic acids research 52 (9) (2024)
Jurre A Steens, Jack P K Bravo, Carl Raymund P Salazar, Caglar Yildiz, Afonso M Amieiro, Stephan Köstlbacher, Stijn H P Prinsen, Ane S Andres, Constantinos Patinios, Andreas Bardis, Arjan Barendregt, Richard A Scheltema, Thijs J G Ettema, John van der Oost, David W Taylor, Raymond H J Staals
Type III-B CRISPR-Cas cascade of proteolytic cleavages. Science (New York, N.Y.) 383 (6682) (2024)
Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals, Johannes Hohlbein
Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Nucleic acids research 52 (9) (2024)
Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals, Johannes Hohlbein
Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Nucleic acids research (2024)
Jurre A Steens, Jack P K Bravo, Carl Raymund P Salazar, Caglar Yildiz, Afonso M Amieiro, Stephan Köstlbacher, Stijn H P Prinsen, Ane S Andres, Constantinos Patinios, Andreas Bardis, Arjan Barendregt, Richard A Scheltema, Thijs J G Ettema, John van der Oost, David W Taylor, Raymond H J Staals
Type III-B CRISPR-Cas cascade of proteolytic cleavages. Science (New York, N.Y.) 383 (6682) (2024)
Jurre A Steens, Jack P K Bravo, Carl Raymund P Salazar, Caglar Yildiz, Afonso M Amieiro, Stephan Köstlbacher, Stijn H P Prinsen, Ane S Andres, Constantinos Patinios, Andreas Bardis, Arjan Barendregt, Richard A Scheltema, Thijs J G Ettema, John van der Oost, David W Taylor, Raymond H J Staals
Type III-B CRISPR-Cas cascade of proteolytic cleavages. Science (New York, N.Y.) 383 (6682) (2024)
Jurre A Steens, Jack P K Bravo, Carl Raymund P Salazar, Caglar Yildiz, Afonso M Amieiro, Stephan Köstlbacher, Stijn H P Prinsen, Ane S Andres, Constantinos Patinios, Andreas Bardis, Arjan Barendregt, Richard A Scheltema, Thijs J G Ettema, John van der Oost, David W Taylor, Raymond H J Staals
Type III-B CRISPR-Cas cascade of proteolytic cleavages. Science (New York, N.Y.) 383 (6682) (2024)
Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals, Johannes Hohlbein
Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Nucleic acids research 52 (9) (2024)
Jurre A Steens, Jack P K Bravo, Carl Raymund P Salazar, Caglar Yildiz, Afonso M Amieiro, Stephan Köstlbacher, Stijn H P Prinsen, Ane S Andres, Constantinos Patinios, Andreas Bardis, Arjan Barendregt, Richard A Scheltema, Thijs J G Ettema, John van der Oost, David W Taylor, Raymond H J Staals
Type III-B CRISPR-Cas cascade of proteolytic cleavages. Science (New York, N.Y.) 383 (6682) (2024)
Lorenzo Olivi, Cleo Bagchus, Victor Pool, Ezra Bekkering, Konstantin Speckner, Hidde Offerhaus, Wen Y Wu, Martin Depken, Koen J A Martens, Raymond H J Staals, Johannes Hohlbein
Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Nucleic acids research 52 (9) (2024)
Despoina Trasanidou, Patrick Barendse, Evgenios Bouzetos, Laura de Haan, Hans Bouwmeester, Raymond H J Staals, Ioannis Mougiakos, John van der Oost
Efficient Genome and Base Editing in Human Cells Using ThermoCas9. The CRISPR journal (2023)
Despoina Trasanidou, Ana Potocnik, Patrick Barendse, Prarthana Mohanraju, Evgenios Bouzetos, Efthymios Karpouzis, Amber Desmet, Richard van Kranenburg, John van der Oost, Raymond H J Staals, Ioannis Mougiakos
Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli. Communications biology 6 (1) (2023)
Thomas Swartjes, Peng Shang, Dennis T M van den Berg, Tim Künne, Niels Geijsen, Stan J J Brouns, John van der Oost, Raymond H J Staals, Richard A Notebaart
Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides. The CRISPR journal 5 (4) (2022)
Prarthana Mohanraju, Chinmoy Saha, Peter van Baarlen, Rogier Louwen, Raymond H J Staals, John van der Oost
Alternative functions of CRISPR-Cas systems in the evolutionary arms race. Nature reviews. Microbiology 20 (6) (2022)
Luis Garcia Morales, Niek H A Savelkoul, Zoë Robaey, Nico J Claassens, Raymond H J Staals, Robert W Smith
Ten simple rules for building an enthusiastic iGEM team. PLoS computational biology 18 (3) (2022)
Wen Y Wu, Simon A Jackson, Cristóbal Almendros, Anna C Haagsma, Suzan Yilmaz, Gerrit Gort, John van der Oost, Stan J J Brouns, Raymond H J Staals
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types. The CRISPR journal 5 (4) (2022)
Jurre A Steens, Carl Raymund P Salazar, Raymond H J Staals
The diverse arsenal of type III CRISPR-Cas-associated CARF and SAVED effectors. Biochemical Society transactions 50 (5) (2022)
Jurre A Steens, Yifan Zhu, David W Taylor, Jack P K Bravo, Stijn H P Prinsen, Cor D Schoen, Bart J F Keijser, Michel Ossendrijver, L Marije Hofstra, Stan J J Brouns, Akeo Shinkai, John van der Oost, Raymond H J Staals
SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation. Nature communications 12 (1) (2021)
Constantinos Patinios, Sjoerd C A Creutzburg, Adini Q Arifah, Belén Adiego-Pérez, Evans A Gyimah, Colin J Ingham, Servé W M Kengen, John van der Oost, Raymond H J Staals
Streamlined CRISPR genome engineering in wild-type bacteria using SIBR-Cas. Nucleic acids research 49 (19) (2021)
Max Finger-Bou, Enrico Orsi, John van der Oost, Raymond H J Staals
CRISPR with a Happy Ending: Non-Templated DNA Repair for Prokaryotic Genome Engineering. Biotechnology journal 15 (7) (2020)
Bridget N J Watson, Reuben B Vercoe, George P C Salmond, Edze Rients Westra, Raymond H J Staals, Peter C Fineran
Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nature communications 10 (1) (2019)
April Pawluk, Raymond H J Staals, Corinda Taylor, Bridget N J Watson, Senjuti Saha, Peter C Fineran, Karen L Maxwell, Alan R Davidson
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nature microbiology 1 (8) (2016)

Raymond H J Staals.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Raymond H J Staals